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Previous studies on the ontogeny of the specific immune  response shortly 
after birth in several species (1-10) have indicated that newborn Chicks, guinea 
pigs, rabbits, and human beings form little or no detectable antibody in response 
to antigenic stimulation, but develop this ability between 2 and 4 weeks of age. 
In several known situations,  however, such antigenic  stimulation is not lost 
upon  the  newborn  animal  but  results  in  a  highly  specific hiatus  in  his  im- 
munological capacity which persists after maturity.  The studies establishing 
this last concept are reviewed exhaustively by Billingham,  Brent, and Medawar 
(11) particularly in reference to "acquired tolerance" to homografts. In respect 
to less complex antigens, the investigations of Hanan and Oyama (12), Dixon 
andMaurer  (I3),  and Cinader and Dubert (14) have indicated that multiple 
injections of heterologous plasma proteins during  the neonatal period result 
in prolonged and specific inability to respond immunologically to the injected 
protein. 
This investigation has been concerned with the mechanisms which govern 
the early development of specific immunity in mammals and particularly the 
unresponsive state resulting from neonatal  exposure  to antigen,  The present 
paper  describes  the  production  of  a  prolonged  state  of  immunological  un- 
responsiveness in rabbits by a  single  injection of defined protein antigens  at 
birth,  and  defines  the  amount  of antigen  required,  the  duration  of the  un- 
responsive state, the degradation of antigen in unresponsive animals,  and also 
describes a number of attempts to produce an analogous state with a variety 
of bacterial antigens.  A preliminary report of these studies has appeared else- 
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where  (15)?  A  subsequent  paper  will be  concerned with  the  definition of im- 
munological response of the rabbit from birth to maturity in terms of antibody 
formation as well as the unresponsive state. 
Experimental Procedures and Methods 
The  experimental  design  employed  throughout  most  of  this  investigation  consisted  of 
giving litters of newborn New Zealand albino rabbits a  single intraperitoneal injection of a 
defined antigen, allowing the animals to stay with the doe until weaned, and then at 3 to 
4 months of age, or in some experiments at various other intervals, attempting to immunize 
them with the antigen injected at birth. In experiments in which it was required to immunize 
the animals before 90  days of age, half of each litter were used as a  non-injected control 
group and identified by India ink tattooing on the ear. However, the uniform response at 
3 to 4 months of age of this stock of animals to the immunizing schedule employed soon made 
this  step  unnecessary.  When  initial immun;~-~tion  was  to be attempted  at  more than  90 
days of age, whole litters born within 1 to 3 clays of the injected litters were set aside as con- 
trols. The mortality from handling and injecting the newborn animals was not different in 
injected and control groups similarly handled, and appeared to be significantly reduced when 
the person who fed, watered, and handled the rabbits regularly, handled and held the new- 
born animals for injection. The animals were fed a  standard antibiotic-supplemented ration 
except in the experiments in which the effect of streptococcal infection was assessed,  when 
a ration not supplemented with antibiotic was supplied. 
Protdn a~igens.--Various lots of crystalline bovine albumin (BSA) obtained from Armour 
and Company, crystalline ovalbumin (EA) obtained from Worthington Chemical Company, 
and pooled human gamma globulin (HGG) from recently outdated lots prepared by Squibb 
Laboratories, were dissolved at 4°C. in pyrogen-free 0.145  M NaC1,  and sterilized by Sietz 
filtration. The macroglobufin employed was isolated from the plasma of a patient with macro- 
globuiinemia by repeated precipitation at low ionic strength,  employing aseptic technique, 
and  1:10,000  final concentration of merthiolate was added  to  the  solution  as  a  preserva- 
five. This material was apparentlyhomogeneons electrophoretieally and in the ultracentrifuge. 
After determination  of the protein content  of the various antigens by the biuret  method, 
the concentration was adjusted so that the desired amount of antigen could be administered 
in 0.1 to 1.0 mi. 
Immunization procedures.--In the  earlier  experiments  the  initial  attempt  to  immunize 
the rabbits  injected at  birth consisted of two intravenous injections,  10  days apart,  of 10 
rag.  of the antigen, and was started when the animals were 90 to 120 days of age. Bleedinga 
were then taken at weekly intervals, or more frequently, until antigen was no longer detect- 
able in the serum, when at least two subsequent  bleedings were made for antibody  deter- 
ruination. 
The duration of the unresponsive state induced by neonatal injection of BSA in groups 
of rabbits which had failed to respond to antigenic challenge at 3 to 4 months of age, was 
assessed  by rechallenge at approximately 4 months intervals. These subsequent attempts at 
immunization were made by one of two methods.  Most animals received 15 to 25 mg. per 
kilo  BSA,  or  appropriate  antigen,  intravenously,  following a  prebleeding,  and  were  bled 
weekly or more often, until the antigen disappeared  from the serum.  Some groups of ani- 
mals received an intradermal injection of 10 to 80 rag.  BSA incorporated  in a  water-in-oil 
emulsion with an equal volume of adjuvant  mixture (bayol F, containing one per cent lano- 
1 These experiments were also presented  in part  before the Central Society for  Clinical 
Research,  Chicago, November 6,  1956;  other portions were presented before the American 
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fin and  1 mg. per ml. heat-killed Mycobactcrlur~ butyricnm) and were bled weekly for anti- 
body determination. 
In all the studies blood specimens were taken aseptically from the marginal ear vein or 
by heart puncture, and allowed to clot at room temperature for  1 hour and then kept at 4°C. 
until processed. Within 24 hours after bleeding the sera were quickly frozen at  --70°C. in 
rubber-stoppered pyrex tubes and stored at -20°C. until used. 
Qualitative determinatlon of antigen disappearance from the circulating blood was made by 
a  capillary tube precipitin method. 0.2  X  100 mm. capillary  tubes containing the unknown 
serum and a  potent rabbit antiserum were incubated at 37°C. for  1 hour, then at 4°C. for 
48 hours. Final readings for the presence or absence of precipitate were made at 48 hours. 
Normal serum was always included as  a  control.  By employing known  concentrations  of 
antigen in normal rabbit serum it was determined that as little as 0.3 microgram antigen N 
per ml. was detectable with the available rabbit antisera. 
Quantitative immunochemical determination of the amount of antigen present in the serum 
at intervals after challenge was made,  employing standardized  rabbit antisera,  the precip- 
itate  nitrogen  being  estimated  by  a  micromodiflcation  of  the  Heidelberger-MacPherson 
(16)  method  using  the  Folin-Ciocalteu  reagent,  or  the  microKjeldahi method,  depending 
upon the amount of precipitate nitrogen, and the resulting data are expressed as micrograms 
antigen nitrogen per milliliter of serum. 
Determination of antibody.--In  most of the experiments reported the presence or absence 
of antibody was determined by the capillary tube precipitin technique. The antibody con- 
centrations given in one of the tables were determined quantitatively by the same techniques 
as antigen concentration and expressed as micrograms of antibody nitrogen per milliliter of 
serum. In some experiments the Ouchterlony agar diffusion plate method (17) was employed, 
placing 0.5 mi. antigen (5 to 50/zg. antigen N  per mi.) in the center well and the 0.5 mi. of 
undiluted sera in surrounding wells. 
Dipl~heria antitoxin de~erminalion.--l.O ml. fluid diphtheria toxoid (lot 1867-28A), kindly 
supplied by the Lederle Laboratories Division of the American Cyanamid Company,  Pearl 
River, New York, and  containing 136 Lf toxoid, was given to newborn rabbits  and  again 
as a  subsequent  immunizing dose. The presence of circulating antitoxin was inferred from 
reversal of a  positive Shiek reaction induced by giving 0.1  mi. of a  dilution of diphtheria 
toxin  (Lederle,  lot  2286  4733A)  containing 0.01  unit  toxin per  ml.  (standardized  against 
National  Bureau of  Standards  horse antitoxin)  intradermally,  and  examining the  area  72 
hours later for presence or absence of a reaction. 
Group A  streptococcal antibody determina~ion.--A Group A, type 30, rabbit  virulent strep- 
tococcus,  obtained  from  Dr.  Gene  $tollerman  of  Northwestern  University,  Chicago,  was 
used for all streptococcal experiments. Vaccines of heat-killed  organisms were prepared and 
administered according to a  schedule suggested by Lancetield (18).  The presence of anti-M 
and  anti-C in the rabbits'  sera was  detected by Lancefield's method,  using appropriately 
absorbed  hot acid extracts.  Experimental infections were induced  by giving 0.2  ml. of an 
18 hour  tryptose  phosphate  broth culture of the microorganism  intradermally.  Sensitivity 
to streptokinase was determined by injecting 0.2 mi. of saline dilution of commercial strepto- 
kinase-streptodornase  (varidase)  containing  500  units  of  streptokinase  per  ml.  The  skin 
tests were considered positive if an area of erythema and  induration  1 cm. in diameter or 
greater was present at 48 hours. 
Typhoid  antibody de~ermlnation.--1.0 ml.  typhoid-paratyphoid  vaccine  (Wyeth  TAB 
vaccine) was given intraperitoneally to newborn rabbits, and again as immunizing  injection 
at 3 months of age. Bleedings were taken 4 and 10 days later, and antibody titers against the 
O  and  H  antigens were determined by tube agglutination.  The test  antigens were kindly 
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Tuberculin sensiti~ity.-A culture  of the Phipps  strain  of  BCG  was  obtained  from  Dr. 
Gardner  Middlehrook  of  Denver,  Colorado,  and  maintained  on  Petroff  agar  slants.  The 
five organisms were harvested by scraping the agax surface, suspended in 0.145 M NaC1  as 
a heavy opaque suspension,  and injected in a  1.0 ml. volume in newborn rabbits. The subse- 
quent  immunization  attempts  were made  by giving weekly intradermal  injections of 0.2 
ml. of the living BCG suspension,  and tuberculin sensitivity was detected by weekly testing, 
using 0.1  ml. of a  1:100 dilution of old tuberculin intradermally. A  positive reaction con- 
sisted of 1.0 cm. or greater area of erythema and induration 48 hours after the test was ap- 
plied. The groups of rabbits which had received 1.0 or 2.0 ml. of undiluted old tuberculin 
intraperitoneally at birth were sensitized and tested in the same manner as the BCG group. 
Meningococcul endotoxin.- -0.2 ml. of a  1:10 dilution  of  the  crude  agar  washings (19) 
was given to  newborn  rabbits,  representing  the maximum  amount  tolerated  by newborn 
rabbits  without  significant mortality resulting from the  endotoxin alone.  The subsequent 
challenge in these experiments consisted in determining: (a)  the febrile response to an intra- 
venous administration of 1.0 ml. or a  1 : 10,000 dilution of the endotoxin; and (b) the incidence 
of the local Shwartzman reaction after an intradermal injection of 0.2 ml. of a  1:10 dilution 
of meningococeal endotoxin followed in  18 hours by an intravenous injection of 1.0 ml. of 
a 1: 80 dilution. 
Cell transfer studies  were performed by a modification of the methods of Roberts and Dixon 
(20),  and  Harris,  Harris,  and  Farber  (21),  employing donor animals  which had  been  im- 
munized by intravenous injections of alum-precipitated BSA. In each experiment the time 
of the last injection before transfer is given. The spleen,  mesenteric, popliteal, and axillary 
lymph nodes were obtained under aseptic conditions immediately after sacrificing the donor 
by exsanguination,  and  were kept in standard  Tyrode  solution containing 0.125  per cent 
Knox  gelatin while the  celia  were teased  out with needle and  forceps.  The  preparations 
were then strained through 50 mesh stainless steel gauze, and  100 units of penicillin and  1 
rag.  of streptomycin per ml. were added.  The number  of cells was counted in a  standard 
hemocytometer chamber, viability estimated by trypan blue staining, and  the cell suspen- 
sion was then injected intramuscularly into the recipients. Siliconized glassware was employed 
throughout the procedure. Estimated  viability of the cells in the experiments reported var- 
ied from 70  to 95 per cent, and the time elapsing from sacrifice of the donor to injection of 
cells did not exceed 2 hours in any experiment. In experiments in which the recipients aim 
received BSA, this was  given intravenously at the  time of  cell transfer.  Blecdings of the 
recipients were made at 2 to 3 day intervals for 11 to 18 days and the presence  of antigen 
or antibody determined  by the methods described above. Recipients designated as x-irradi- 
ated received 400 roentgens total body radiation in a  100 kv. General Electric x-ray machine, 
24 hours prior to cell transfer. 
EXPEI~r~rR-NTAL 
Relation of Neonatal Antigen Dose to Incidence of Unresponsive State 
Preliminary  experiments  indicated  that  prolonged  failure  of  antibody  produc- 
tion  followed a  single injection of  100  rag.  BSA on  the day  of birth  in  rabbits  as 
compared  with uninjected litter mates.  On  this basis  groups  of three  to five litters 
of rabbits  were given a  single intraperitoneal  injection within  12  hours  of birth  of 
amounts  of  BSA ranging  between  0.001  and  100  rag.  Four  litters  of rabbits  born 
within the same 2 week period were kept as controls. Between 87 and  120  days  later 
the  survivors  of  the  groups  injected  at  birth  and  the  control  litters  received two 
intravenous  injections of  10  rag.  BSA  10  days  apart,  and  the presence of  BSA or 
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of this attempted immuniz.ation in relation to the amount of BSA received at birth 
is given in Table I. 
In substantially all the animals given 100, 50, or 20 rag. BSA at birth,  BSA was 
present in the sera longer than 2  weeks and no precipitating antibody was produced 
as a  result of this stimulus. Approximately one-fourth of the rabbits which received 
10 rag. at birth produced detectable antibody and nearly  all the rabbits which re- 
TABLE I 
Influence of a Single Neonatal Injection of BSA upon the Immune Response to BSA in Rabbits 
between 87 to 120 Days of Age 
Amount BSA injected 
during neonatal period* 
mg. 
100 at birth. 
;0 at birth.. 
20 at birth.. 
10 at birth.. 
1 at birth.. 
]. 8 at birth. 
3.1 at birth. 
3.01 at birth. 
3.001 at birth. 
100 at day 3. 
100 at day 9. 
100 at day 15. 
100 at day 17. 
None.. 
No. in group 
24 
12 
12 
14 
7 
4 
3 
2 
4 
47 
4 
16 
16 
18 
No. with detectable BSA in serum 
within given interval after second 
immunizing injection of BSA 
7-11 
22 
11 
11 
13 
5 
1 
0 
0 
0 
44 
3 
6 
4 
14-18  21-34 
22  6 
11  1 
9  5 
9  5 
1  0 
0  0 
0  0 
0  0 
0  0 
41  0 
2  2 
4  2 
4  0 
1  0 
No. with 
detectable 
anti-BSA in 
se~IHI 
3 
1 
7 
12 
16 
* Litters of rabbits were given the indicated amounts of BSA intraperitoneally on the 
designated day of life. After 87 to 120 days the survivors were challenged  with two intra- 
venous injections of BSA,  10 days apart, and bled weekly or more often thereafter until 
antigen had disappeared or antibody had appeared in the serum. 
ceived 1 mg. or less at birth responded at this age by developing detectable antibody, 
as did 16 of the 18 control animals. 
From these data it would appear that the minimal amount of BSA given at 
birth which is required to induce unresponsiveness lasting 3  to 4  months in a 
high percentage of rabbits, is between 10 and 20 rag. 
Relation between Age at Neonatal Injection and Incidence of Unresponsive 
State 
As a  part of the first experiment, litters of rabbits were given  100  nag.  of BSA 
intraperitoneally on  the 3rd,  9th,  15th,  or  17th  day of life, and  their response to 232  IMMUNOLOGICAL  UNP~SPONSIVEI~SS  IN  RABBITS 
antigenic  challenge  tested at 87 to 120 days as above.  The results (also shown in 
Table I) indicate that while the majority of the 3 day group did not respond to stimu- 
lation, one-fourth of the 9 day group, one-half of the 15 day group, and three-fourths 
of the 17 day group were able to form antibody to BSA at 3 to 4 months of age. 
These data indicate  that  unresponsiveness  lasting  3  to  4  months can  be 
induced,  with  the  relatively large  amounts  of BSA  employed,  only if  the 
antigen was given during the first 2 weeks of life, unresponsiveness occurred in 
a small but significant proportion of animals when the antigen was given at 15 
to 17 days of age. 
Duration of the Unresponsive State 
Groups of animals given 10 to 100 mg. BSA during the neonatal period, and found 
to be unresponsive  at 87 to 120 days as described  in the preceding sections,  were 
rechaUenged at 90 to 120 day intervals (exceptions noted) for up to 620 days. The 
challenge in each instance consisted of a single intravenous injection of BSA, usually 
15 nag. per kilo. Eighty-five to 95 per cent of normal rabbits of comparable weight, 
which were included  in each challenge group as controls for the antigenicity of the 
BSA, deared antigen within 14 days and developed  circulating antibody. Table II 
gives the results  of attempts to challenge the unresponsive  groups  in terms of the 
occurrence  or failure of precipitating antibody production. 
These data indicate that most of the animals which received 20 to 100 nag. 
of BSA at birth failed to produce antibody over the 620 day period of study, 
and as will be shown,  they continued to show prolonged antigen clearance. 
Three of the  seven animals  of the  10 rag.  group produced antibody on  the 
third challenge at 380 days, but four were unresponsive on each challenge. The 
three rabbits which produced antibody at 380 days had cleared antigen rapidly 
(half-life =  1.9, 2.6, 4.0 days) after the 194 day challenge in contrast to their 
initial challenge, but failed to produce detectable circulating antibody. Of the 
group which received 100 rag. at 3 days of age, three animals were persistently 
unresponsive through  the  fifth challenge.  All but  one of the  15  day group 
which were unresponsive at the initial challenge showed evidence of an immune 
response by the third immunization attempt. 
The data appeared to support the concept that when the unresponsive state 
is induced sufficiently early in the neonatal period with threshold amounts of 
BSA, it is essentially permanent. The data also suggested that when it is pro- 
duced with smaller amounts of antigen (e.g. 10 rag.), or later in the neonatal 
period, the unresponsive state is either incomplete or not permanent. However, 
the interpretation that the unresponsive state is permanent is based upon the 
assumption that the amounts of antigen employed for challenge on each oc- 
casion had no effect upon its duration. The experiments summarized in Tables 
IX and IV, however, offered several observatio,  ns casting doubt upon the validity 
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challenge prior to which five animals which had received 100 rag. at 3 days of 
age,  produced  antibody.  By  contrast  the  interval  between  injections  was 
always less  than  200  days,  and  averaged  120 days in  the  persistently  unre- 
sponsive group. Data to be presented  in another  section also hinted  strongly 
that repeated attempts at immunization were possibly responsible for the ob- 
served persistence  of unresponsiveness. 
TABLE II 
Results  of Repeated Intravenous  Injections  of BSA  in Rabbits Wklch Received Variou~ 
Amounts of BSA in the Neonatal Period and Were Unresponsive to BSA  Challenge at 
87 to 120 Days of Age 
No. of challenge* 
1 (see also 
Table I) 
2 
3 
4 
5 
Age range of 
group at time of 
challenge 
days 
87-120 
154-211 
267-411 
472-531 
532-620 
Anti-BSA production 
Injected at birth  100mg.  injected 
100mg.  10mg.  15 days 
2/24~ 
0/22 
1/14 
0/8 
0/8 
50 rag.  20 rag. 
o/12  1/12 
0/3 
0/2  1/s 
o/1 
o/1 
3/14 
0/7 
3/7§ 
0/4 
O/4 
3 days  9 days ,.[ 
3/47  1/4 
1/lS  1/3 
6/9ll  0/2 
0/3  o/1 
018  0/1 
7/16 
z/8 
z/5¶ 
o/1 
o/1 
* Antigenic challenge on each occasion other  than the original challenge (see Table 1) 
consisted of an intravenous  injection of 15 rag. per kilo BSA, followed by weekly bleedings 
until antigen was no longer detected or maximal antibody titer had been achieved. Animals 
which produced circulating antibody were discarded before the succeeding challenge. 
Numerator,  those  in the  challenged group which  produced  detectable  antibody; de- 
nominator, number in group challenged within age interval. 
§ Three animals producing antibody showed rapid clearance of antigen on prior challenge, 
but no detectable antibody. 
[[ Five of the 6 animals which produced antibody in this group had not received BSA since 
the first challenge (270 to 300 day interval). 
¶ Three a~imals which did not produce antibody showed rapid clearance after this chal- 
lenge, but died before any subsequent challenge. 
As a result of these earlier studies, experiments were designed to obtain data 
on the duration of the unresponsive state in the absence of repeated antigenic 
challenge. 
Litters of rabbits were given 100, 10, 1.0, or 0.1 mg. BSA intraperitoneally at birth; 
groups receiving each amount were challenged with litter mate controls only once, 
at intervals which depended upon the amount given at birth.  The results  of these 
attempted  immunizations,  given in  Table III, show dearly that  the  unresponsive 
state is of a finite duration, related generally to the amount of antigen administered 
at birth. Sutficient numbers of groups were not included to define exactly the duration 
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longer than 135 and less than 189 days in the 100 rag. group, between 103 and 189 
days in the 10 nag. group, between 62 and 100 days in the 1 nag. group, and between 
47 and 62 days in the 0.1 nag. group. 
These data, while establishing that unresponsiveness is not permanent, also 
indicate that  it  was  greatly prolonged  in  the  prior  experiments  by  the  in- 
crements of antigen required to elicit a  specific immune response. 
TABLE HI 
D~a~  of Unresp~i~en~s in Rabbits Given 0.1, 1.0, 10.0, or 100.0 Mg. BSA at Birtk,  and 
Challenged only Once 
Amount injected  at 
birth 
I00 
10 
1.0 
0.I 
Age at time of 
challenge* 
days 
lOO 
135 
163 
189 
230 
250 
89 
103 
180 
64 
122 
31 
47 
62 
109 
No. producing  detectable antibody 
No. in  group 
0/4 
0/3 
3/7 
4/5 
4/S 
3/3 
0/3 
3/6 
5/5 
0/3  (5/s)~ 
3/4 
o/8  (5/5) 
4/5  (8/9) 
s/5  (6/6) 
* Litters of rabbits were given the indicated amount of BSA at birth, and challenged only 
once at the indicated age. At that time they were given 15 mg. per kilo BSA intravenously, 
and bled serially for detection of precipitating antibody. 
Results of simultaneous  immunization in litter mates which had received no antigen at 
birth are shown in parentheses. 
Effect of Intradermal Injections of BSA in Unresponsive Rabbits 
It seemed possible that more intensive and sustained antigenic stimulation might 
induce a  specific immune response in unresponsive animals, which failed to respond 
when challenged intravenously with similar amounts of antigen. Accordingly, groups 
of rabbits which had received from 50 to 200 nag. BSA at birth, and which had been 
demonstrated on one or more occasions to be unresponsive, were given intradermal 
injections of BSA, incorporated in complete Freund's adjuvants in amounts ranging 
in various attempts from 10 to 80 rag. Table IV shows the result of these immuniza- 
tion attempts. Animals getting BSA--adjuvant mixture failed to respond with anti- RICHARD  T.  SMITH  AND  ROBERT  A.  BRIDGES  235 
body production when less than  100 days had passed  since intravenous challenge. 
However, in a group challenged after a 145 day interval, half produced antibody and 
all the rabbits stimulated at 209 or 226 day intervals responded. Animals with identical 
prior injection histories were not available as controls to receive intravenous injec- 
tions of plain BSA in identical amounts. However, comparable data on animals with 
similar, but not identical injection histories, which were injected intravenously with 
plain BSA, indicate that the intradermal administration of BSA in adjuvants appar- 
ently  provided  a  greater  antigenic  stimulus  than  plain  BSA given intravenously. 
This interpretation  must be made cautiously, however, since large sterile abscesses 
TABLE IV 
Results of IntradermaI Injections of BSA in Previously Unresponsive Rabbiis of Various Ages 
and Intervals Since Prior Antigenic Challenge* 
Interval  since  prior 
injection 
days 
60 
90 
90 
145 
2O9 
226 
235-279:[: 
Age 
days 
284 
190 
288 
265 
312 
330 
Amount of 
intradermal BSA 
mg. 
4O 
8O 
10 
35 
80 
8O 
335-389  10-45 (intravenous) 
No. producing anti-BSA 
No. in  group 
0/4 
0/2 
0/3 
1/2 
3/3  1 
1/1 
1/7 
* Rabbits which had received 50 to 200 rag. BSA at birth,  and which had been found 
unresponsive to one or two prior BSA injections, were given BSA intradermally  incorporated 
in complete Freund's adjuvants, and serum specimens taken at weekly intervals  thereafter 
tested  for the presence or absence of BSA or anti-BSA. 
This group, consisting of rabbits which had received 50 to 100 rag. BSA at birth and 
which had been unresponsive on one prior occasion, was challenged within the stated intervals 
by intravenous  injection of plain BSA, and is shown here for comparison with intradermally 
injected  animals  with  a  similar  injection  history.  Note  that  this  group  was  not  run 
concurrently with the intradermal  groups, and therefore cannot be considered a true control. 
produced  by administering  adjuvant  mixtures  were  often  associated  with  loss  of 
weight in the animals and, in a few observations, with extremely rapid non-immune 
disappearance of intravenously administered BSA, suggesting a high rate of protein 
turnover such as occurs in dogs with turpentine abscesses (22). 
These results add to the evidence that unresponsiveness is not a  permanent 
state, and that its duration is related to the interval since prior antigen adminis- 
tration as well as to the original dose received. 
To complete the evidence that the precipitating antibody which appeared in 
the serum of previously unresponsive rabbits  after those challenges described 
in th  e previous two sections was indeed anti-BSA, and not antibody against a 
minor component of the antigen,  the agar diffusion technique was employed. 
The serum of each animal which produced anti-BSA represented  in Tables I, 236  IwrMUNOLOGICAL  UNRESPONSIVENESS  IN RABBITS 
II, and IV, when allowed to diffuse and interact with crystalline BSA, showed 
a single band varying somewhat in width, which "cornered" cleanly with anti- 
BSA of known homogeneity. This  "reaction of identity" provides evidence 
that the antibody produced was not directed against trace components of the 
antigen (23). 
Unresponsiveness to Other Heterologous Proteins Induced by Neonatal 
Injection 
A single injection  of ovalbumin  (100 rag.,  10 nag., and  1 nag.), human gamma 
globulin (166 mg.),or a human maeroglobulin (105 nag.) was given intraperitoneally  to 
litters of rabbits on the day of birth. The results of these experiments, summarized in 
Table V, show that neonatal injection of soluble proteins  from three animal species, 
varying in estimated molecular weight from 40,000 (EA) to approximately  1,000,000 
(maeroglobulin), inhibited  the immune response to the same antigenic challenge at 
100 to 167 days. 
As with BSA, the effectiveness  of EA in  inducing unresponsiveness appeared 
to be related  to the amount given at birth,  requiring  more than 10 mg. for un- 
responsiveness of 167 days' duration. EA  unresponsiveness  also appears not 
to be permanent,  since by 262 days all but  two  of the rabbits receiving 
the largest  amount of EA had produced antibody. 
In other experiments which are not presented here in detail,  unresponsivc- 
ness was induced to human serum albumin (fraction  V) and bovine gamma 
globulin (Armour). It is of interest  that since  both of these antigens were rela- 
tively  inhomogeneous, precipitating  antibody formed in response to unidenti- 
fied  minor components at the time of the second antigenic  challenge while the 
major component  was cleared slowly and no precipitating antibody was de- 
tected. Similarly, a small amount of precipitating  antibody to a minor com- 
ponent of HGG  was observed in the two animals challenged the second time 
at 280 days (Table V). 
Ckaracteristics of Antigen Disappearance in Unresponsive  Rabbits 
As is shown in Table I,  antigen clearance as compared with controls was 
greatly prolonged in those animals failing to produce anti-BSA. Since the rate 
and character of antigen disappearance are related closely to antibody forma- 
tion to heterologous proteins (24, 25),  it was of interest to examine quantita- 
tively the rate of antigen disappearance in rabbits which were unable to form 
precipitating antibody. Data from quantitative determinations of the amount 
of BSA in the serum of representative animals, which in retrospect had failed 
to  produce precipitating  antibody and  cleared antigen slowly, were plotted 
semilogarithmically, and half-life estimations taken from those plots in which 
three points or more were available. As will be seen from data summarized in 
Table V-I, and  exemplified by the  plots on three  unresponsive rabbits  chal- 
lenged at 8 months of age (Text-fig. 1), the disappearance rate is linear as long RICHARD  T.  SMITH  AND  ROBERT  A.  BRIDGES  237 
as measurable antigen is present in the serum. No phase of accelerated disap- 
pearance such as characterizes the normal immune response, is observed. Half- 
life values for BSA in the unresponsive animal were all between 5.1  and 8.5 
days (mean value  =  6.86 days), and did not vary significantly on successive 
challenges in the same rabbit. Presumably the progressive decrease in serum 
concentration is related to the rate of catabolic breakdown (26)  of protein in 
the animal, although the possibility of bowel or urinary excretion has not been 
excluded by critical  studies.  The half-life values in unresponsive rabbits  are 
TABLE V 
Respome  to  Human  Gamma Globulin, Human  Macroglobulin, and  O~albumin at  Various 
Ages in Rabbits Which Received  tie Antigen at Birth 
Antigen given at birth and amount 
HGG 166 mg ................... 
None ......................... 
Macroglobulin  105 nag .......... 
None  ......................... 
Ovalbumin 
10O mg  ...................... 
I0 nag  ....................... 
1 nag ........................ 
None ......................... 
Results of initial antigenic 
challenge* 
Age at 
challenge 
days 
lOO 
lOO 
120 
120 
167 
167 
167 
167 
Antibody 
production 
0/55 
5/5 
0/9 
5/6 
0/4 
2/6 
2/4 
7/7 
Results of second antigenic 
challenge 
ch•a 
• at  Antibody 
llenge  production 
days 
280  0/2 
262  1/3 
262  3/4 
262  2/2 
* Rabbits which received the indicated amounts of antigen at birth were chat3enged at the 
stated intervals by a single intravenous injection of 15 rag. per kilo of the antigen given at 
birth, and bled serially for antigen or antibody determination. 
Numerator, number developing detectable antibody; denominator, number of survivors 
in group. 
similar to those measured during the non-immune phase of antigen disappear- 
ance in normal animals in our laboratory, but are somewhat longer than those 
found  by Dixon,  Maurer,  and  Deichmiller  (27)  for homologous  I181-1abelled 
albumin.  The values,  however,  approximate very closely those  obtained  by 
immunochemical methods by Johnson,  Watson,  and  Cromartie  (28),  and by 
Dixon  and  Maurer  (29)  for  adult  rabbits  whose  immune  response  was  in- 
hibited by massive administration of BSA, neonatal injection, or x-irradiation. 
Specificity of the Unresponsive State 
The highly specific character of the unresponsive state produced by neonatal 
exposure  to protein  antigen  has been shown previously  (12,  14).  Table VII 238  IMMUNOLOGICAL UNRESPONSIVENESS IN RABBITS 
gives the results of an experiment showing a  normal immune response to oval- 
bumin in rabbits unresponsive to BSA because of a  single injection of 100 rag. 
given at birth.  These data confirm the previous studies in showing  that  the 
unresponsive state is in a  sense, as immunologically specific as the normal im- 
mune response. 
TABLE VI 
Rates of Disappearance of Intravenously Injected BSA from Serum of Unresponsiw Rabbits* 
Animal  No. 
41-72 
41-74 
41-75 
41-76 
164 
156 
41-38 
41-37 
159 
202 
41-69 
41-58 
41-66 
151 
183 
192 
Amount at birth 
100 nag. 
50 mg. 
10 nag. 
100 (9 days) 
100 (15 days) 
100 (15 days) 
Half-life of BSA at varying age 
Age range, days 
100-113  187-201  322-329 
days 
6.8 
6.2 
6.6 
6.0 
8.6 
4.7 
5.9 
5.9 
8.5 
days 
7.3 
8.4 
6.0 
5.1 
days 
6.0, 6.9 
8.3 
7.4 
5.3 
7.1 
6.4 
7.9 
7.8 
7.0 
8.0 
5.9 
* Half-lives measured on serum of animals which in retrospect were repeatedly unrespon- 
sive to BSA because  of neonatal injection of that antigen. 
Unresponsiveness  to BSA Induced by Oral Administration at Birth 
Absorption of intact proteins from  the gastrointestinal tract  occurs  during  the 
neonatal period in several species (30-32), and following diarrheal states in human 
infants  (33).  In preliminary experiments 260  rag. of BSA was given to rabbits by 
polyethylene gavage tube on the day of birth; BSA was consistently detected in the 
sera at 1 to 3 days of age in concentration as high as 13.5 rag. per ml. serum. Significant 
absorption of this protein could be demonstrated up until 14 days of age, but after 
that  absorption was irregular and  never more  than  a  trace in amount.  Litters of 
rabbits were then fed varying amounts of BSA at birth by gavage tube, and challenged 
at 54 to 140 days of age to determine their response to BSA. The results of three such RICHARD T. SMITH AND  ROBERT  A. BRIDGES  239 
experiments, given in Table VIII, indicate that an unresponsive state was induced in 
a significant number of rabbits in some litters; however, much greater variation was 
encountered  than  in with  those rabbits  to which  similar  amounts of this antigen 
i  I  I 
30.0 
Z 
<  20.0  6.4 
03 
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I 
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E 
IO.O 
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I00 mg. BSA ot birth 
Se~A  levels following  ~,\ 
I.V. injection  % 
8  months age 
4.0  I 
0  8  16  24 
Days after  Injection 
"I~xT-FIO. 1. Rate of disappearance of BSA in three unresponsive rabbits at 8 month s o 
age, following intravenous  injection of 25 rag. BSA per kilo. The average half-life was 6.4 
days. 
TABLE VII 
Immune Response to O~albumin in BSA-Unresponsive Rabbits 
Group 
Received  BSA  at  birth,  no  response 
at 100 and 230 days... 
Controls, same age, no BSA... 
No. ln group  No. with detectable 
unti-EA* 
No. with Arthus 
reaction 
* Results of  serial  bleedings following  each  intradermal  injection  of  1  rag.  ovalbumin 
every other day for 21 days. 
were given parenterally. Again a relationship between the age at challenge and  the 
outcome of attempted immunization is seen. 
These results appear to be accounted for entirely by the absorption, intact, 
of mounts  of immunologically active protein  comparable  to those  which  in 
other experiments induced unresponsiveness when given intraperitoneally.  The 
only similar experiments  found in the literature  are those of Chase  (34), who 240  TMMU~OLOGICAL UNRESPONSIVENESS  IN  ILg,  BBI'I~ 
by  administering large  amounts of 2,4-dinitrochlorobenzene in  oil  to  adult 
guinea pigs orally, was able to induce a prolonged state of specific unresponsive- 
ness, whereas hypersensitivity to this substance always resulted from intra- 
dermal injection in unfed controls. Inasmuch as 2,4-dinitrochlorobenzene is 
highly irritating, it seems doubtful that this phenomenon could be accounted 
for by direct absorption of the intact chemical, but it does seem possible that 
absorption could occur after conjugation with some substance within the lumen 
of the intestine. 
TABLE  VIII 
Effect of BSA C-4r~ Througha Gastric Tube at Birth onSubsequ~ Immune Response to BSA * 
Litter No.  Age at challenge  Antibody response 
1 
Controls 
2 
3 
4 
Controls 
5 
6 
Controls 
days 
54 
6O 
117 
117 
125 
120 
138 
140 
140 
1/6~ 
7/7 
1/2 
2/5 
1/1 
4/4 
2/2 
S/S 
4/4 
* Litters of rabbits were fed approximately 1.0 ml. of 10 per cent BSA by polyethylene 
gastric tube on the day of birth. At the indicated age these and control litters born at the 
same time were challenged with intravenous BSA, 15 nag. per kilo, and bled serially to detect 
anti-BSA production. 
Numerator, number producing detectable anti-BSA; denominator, number challenged. 
Cell Transfer Studies 
The techniques of transfer of lymphoid tissue from an immune to a  non- 
immune animal were employed in various attempts to overcome inhibition of 
antibody production in the unresponsive animal. The experiments summaxized 
in Table IX show first, that transfer of cells from normal animals previously 
immunized to BSA to an unresponsive host, resulted in antibody production 
comparable to that of the normal recipients. The average antibody content of 
the sera at varying times after the cell transfer in one of the experiments is 
shown graphically in Text-fig. 2. These data indicate that no humoral inhibitor 
of specific antibody production was operating, since the degree of response was 
quantitatively similar to that of normal animals. The data also suggest that 
any antigen which might hypothetically persist from neonatal injection was 
either located in sites which prevented significant binding of the antibody pro- RICHARD  T.  SMITH  AND  ROBERT  A.  BRIDGES  241 
duced by the immune cells,  or was present in amounts too small to affect the 
antibody  levels significantly.  It  is  of considerable interest  that  all  the  un- 
responsive animals  which had produced antibody vicariously, were still un- 
responsive when rechallenged 2 months later, and injected antigen was cleared 
at the same rate as in the last challenge prior to cell transfer. Experiments in 
which  lymph  nodes  and  spleen cells were  transferred from unresponsive to 
normal or normal x-irradiated animals, or from normal rabbits to x-irradiated 
unresponsive recipients without detectable antibody production, suggest that 
the spleen and lymph node cells of the unresponsive rabbit were not actively 
I10 
•/OO 
•  CONTROLS  (AV..  OFZl) 
90  /~ESPONSIVE  (AV.OF  4) 
~  6o 
,~  50 
40  N70  RECIPIffNTS  ~.~.. 
~  30  GOT  I.OXIO  9 SPLEEN  "~q~%,, 
20  CELLS  I.M. 2.2XIO  8 LYMPH  "~"*,,..,,,,, 
NODE CELLS LM.  ~,~'',, 
~  I0  2.0Mg. BSA I.V. 
P  I  I  I  I  I  I  I  I  I  I  I  I  I  f 
O0  2  Zl  6  8  1(9  12  14  16  18 20 22 24. 26 28 ,.30 
DAYS AFTER CELL INJECTION 
TExT-Fro.  2. Anti-BSA titers in normal and BSA-unresponsive rabbits receiving immune 
cells. 
engaged in antibody formation, and required more than a normal environment 
to initiate antibody synthesis. Since it has not been possible here or in other 
reported studies (20)  2 to induce in x-irradiated recipients detectable antibody 
production to heterologous proteins by transferred normal cells,  these experi- 
ments must be regarded as inconclusive on this point. Examination of Wright- 
Giemsa--stained  impression  smears  and  methyl  green-pyrouine-stained  sec- 
tions of the depots of transferred cells during the height of antibody formation, 
revealed large numbers of what appeared to be plasma cells, particularly in the 
most peripheral areas  of the depots.  Similar observations in their studies of 
normal  and  normal  x-irradiated  animals  are  recorded  by  Roberts  and 
Dixon (20). 
2  In a personal communication Dr. F.  J. Dixon and Dr. William Weigle state that they 
have now been able to detect a primary immune response to BGG in unresponsive rabbits 
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Attempts to Alter Response to Various Bacterial Antigens by Neonatal 
Exposure 
Efforts were made to alter the subsequent specific response to a variety of 
bacterial products by injecting a relatively large amount of the antigen at birth. 
TABLE  IX 
PrM~a~ ~  Anffb~yln  BSA-Unresp~ve RabMtsReee~ingBSA-Immune Cells 
Donor 
Mean  No. of  donor 
Group  anti-BSA  cells injected 
into 
titer  recipient 
BSA-immune;  9  days  125.5  (6)~  I  X  10  t  spleen 
postsfimuiatJon  2.2 X 10  s  lymph 
node 
BSA-immune;  41  days  106.$  (5)  5.6 X  10  ~ spleen 
poststimuiation  9.6 X  10  7  lymph i 
node 
BSA-immune;  90  days  12.5 (4) 
poststimulafion 
BSA-unresponsive  0  (3) 
BSA-unrespousive  0  (3) 
Normal  0  (5) 
Recipient* 
Mean 
day  Maximum 
BSA  No.  mti-  antibody 
Group status  given  in  gen  titer 
group  :leaf- 
ed 
rag.  ~g. N/ml. 
(a) Unresponsive  2.0  4  5  83.7  (4)~ 
(b)  Normal  2.0  4  7  94.5  (4) 
(s) Unresponsivel  2.0  3  S  11.0 (3) 
(b) Normal  2.0  3  5  11.0 (3) 
(c) Normal,  x-  2.0  2  5  27.0  (2) 
irradiated 
1.4 X  10  s spleen  (a) Unresponsive 
1.8 X  10  s lymph  (b) Normal 
node 
7.3 X  108 spleen 
5.6 X  108 lymph 
node 
7 X  l0  s  spleen 
1.8  X  I0  s  lymph 
node 
6.7 X  10  s spleen 
1.8 X  108 lymph 
node 
1.0  2  6 
1.0  2  6 
(a) Normal,  x-i  2.0  3  12 
irradiated 
16.s (2) 
11.0 (2) 
0 
(b)  Normal,  x-  2.0  4  IS  0 
irradiated 
(a) Normal,  x-  5.0  2  11  0 
irradiated 
(b)  Unresponsive  $.0  3  18  0 
x-irradiated 
* Recipient rabbits were bled and the presence of antigen or titer of antibody determined at I to 3 day in- 
tervals  after  receiving  the  cells  and  BSA  indicated.  The  mean  day  of  antigen  clearance  is  an  aver- 
age of the latest day antigen was detected in serum of each rabbit in the group. 
~; Number in parentheses refers to number of animals comprising the mean value. 
The consistently negative results of studies with a wide spectrum of bacterial 
antigens  are  given  in Table X.  In every experiment the results of the  test 
challenge at 3 months d  age were not significantly different from those in similar 
numbers of control animals  or litter mates. These data cannot be taken as in- 
dicating more than failure under the given circumstances, however. It would ap- 
pear, for example, that Buxton (35) and Kerr and Robertson (8) have succeeded 
in inducing partial inhibition of the immune response to Salmonella puIlorum in TABLE  X 
Respo~e to  Various Bacterial Antigens in Rabbits  Which Received  t~  Antigen  as a  Single 
Neonatal Injection 
Antigen 
employed 
Diphtheria 
toxoid 
Typhoid 
paraty- 
phoid 
Group A 
Antigen injected on  Antigen employed 
in challenge, 
day of birth  mute, and dose 
days 
Fluid  toxoid  130 Lf/  134-141  Fluid toxoid, 130 Lf 
ml.,  2.0  ml.  intra-  per  ml.,  1.0  ml. 
peritoneally  i.m. weekly  3 doses 
Controls, no toxoid  127  Same 
Commercial  heat-killed  62 
vaccine  containing 
10  s  typhoid  organ- 
isms  and  107  para- 
typhoid  A  and  B 
organisms,  per  mL 
2.0 ml. i.p. 
TAB  vaccine  i.v., 
1.0 ml. single dose 
Criteria of response to 
challenge 
Controls--no  antigen  69  Same 
at birth 
Heat-killed  type  30  124-130  (a)  Heat  -  killed 
Reversal of positive Schick 
test  (to  0.1  ml.  1:4000 
toxin), 7 days after 3rd 
injection 
Agglutinating antibody to 
O or H antigens at 4 or 10 
days after  challenge  in 
1:160 dilution or higher 
(a) Development  of  anti- I 
strepto- 
coccus 
Tuberculin 
and/or 
BCG 
Tuberculin 
Knd/or 
BCG 
Bacterial 
endotoziz 
streptococcal  vac- 
cine  I0  s  organisms 
per ml. 2.0 ml., i.p. 
type  30  strepto- 
coccal vaccine 1.0 
ml.  i.v.  3  times 
weekly for 4 weeks 
Controls--no vaccine  124-130  Same 
Heat-kiUed  type  30  124-130 
streptococcal  vac- 
cine  10  s  organisms 
per ml. 2.0 ml., i.p. 
Controls--no vaccine 
Living  BCG  (Phipps 
strain)  in  thick  sa- 
line  suspension  1.0 
ml. i.p. 
Controls--none 
Old tuberculin, 1.0 ml. 
undiluted, i.p. 
Controls--none 
1:10  meningococcal 
culture  filtrate  0.2 
ml.-i.p. 
124-130 
102 
116 
100 
100 
90 
86  Controls--none 
(b) Living 18  hour 
culture,  type  30 
streptococcus, 0.2 
ml. i.d. weekly for 
4 weeks 
Same 
Living BeG (Phip- 
ps  strain)  thick 
saline suspension, 
0.2 ml. i.d. weekly 
in different sites 
Same 
Same 
Same 
Meningococcal  fil- 
trates 
Same 
M  (type 30). 
Development of anti-A 
Anti-M 
Anti-A 
(b)  Development  of  de-I 
layed  hypersensitivity 
to intradermal injection 
of  100  units  streptoki- 
nase-streptodornase 
Same 
Development  of  delayed 
sensitivity to i.d.  injec- 
tion of 1:100 old tuber- 
culin, tested weekly 
Same 
~une 
Same 
(a)  Febrile response to 1.0 
ml. 1:I0,000 dll. i.v. 
(b) Local Shwartzman re- 
action 0.2  ml.  1:10  i.d. 
preparing dose followed 
in  18  hours  by  1.0  ml. 
1:80 i.v. 
No. r1~- 
sponding 
No. in 
group 
8/9 
4/4 
9/9 
8/S 
6/6 
6/6 
s/5 
sis 
6/6 
7/7 
5/S 
S/S 
4/4 
S/S 
(a) 4/4 
(b) 4/4 
(a) 4/4 
(b) 4/4 
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chicks  and  to Trickomonas foetus  in  cattle,  respectively, by neonatal  injec- 
tion. Perhaps,  in view of the demonstration  that relatively large amounts of 
defined protein antigens are required to induce an unresponsive state lasting 
3 to 4 months,  this threshold was never achieved with respect to any single 
antigen by injection of the whole bacterial cell or crude extracts. Too, earlier 
challenge  may have  demonstrated  differences  in  injected  animals  and  con- 
trois, although in experiments to be reported, it has been found that an immune 
response occurs late in the neonatal period even when relatively large amounts 
of bacterial antigens are given at birth.  On the other hand,  the particulate or 
macromolecular  state  of  these  bacterial  antigens  differed  significantly  from 
the proteins, and might, as a result, elicit a different response mechanism. In 
spite of these negative results it appears that further work along these lines is 
warranted. 
DISCUSSION 
In these  studies  attempts have been made to define  semiquantitatively,  the 
state  of  specific  immunological  unresponsiveness,  or  tolerance,  which is  induced 
by injecting heterologous proteins into newborn rabbits. The data presented 
indicate that BSA in amounts exceeding 10 rag.  given intraperitoneally or fed 
orally at birth, inhibits the normal immune response  to this  antigen  for 90 to 
120 days, and that  100 rag.  given intraperitoneally  as long  as  17 days after 
birth results in some inhibition of the immune response tested after this period. 
Similarly,  specific inhibition  of immunity  was induced  with  defined  protein 
antigens of avian and human origin,  ranging  in  estimated  molecular weight 
from 40,000 to one million. The characteristics of the antigen disappearance in 
unresponsive animals  are similar  to the non-immune phase of antigen  elimina- 
tion in normal animals,  but the loss from the serum  continues  exponentially 
so long as measurable amounts are present. 
The data regarding  the duration of the unresponsive state  appear to be of 
particular interest in relation to the possible mechanisms  involved. If the state 
of unresponsiveness once induced by a single threshold dose of the antigen given 
during a critical phase of early postnatal life was found to be permanent and 
independent of further antigenic challenge,  such evidence might be interpreted 
as  indicating  that  a  permanent  adaptive  change  had  occurred  during  the 
neonatal period prior to development of the capacity to recognize the proteins 
as foreign  (or  "non-self"),  and  that  the change  had  been passed on to the 
progeny of the cells originally making the adaptation. Such a mechanism, pro- 
posed by Burner and Fenner (36), finds apparent support in the experiments 
showing  induction  of prolonged tolerance  to homografted  tissue by a  single 
injection of viable reticuloendothelial cells at birth (11, 37-40) and in experi- 
ments demonstrating  tolerance of tumors induced by neonatal  implantation 
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that unresponsiveness to defined protein antigens, at least, is finite, and related 
in duration to the amount of the antigen provided at birth. Further, the addi- 
tional increments of antigen provided by repeated attempts to challenge  the 
unresponsive animal  at  intervals  up  to  620  days,  definitely  prolonged  the 
unresponsive state much longer than  the expected duration for a  given neo- 
natal dose. It is therefore difficult  to reconcile  these data with the adaptation 
hypothesis as it has been stated~ 
The  data presented,  on the other hand, appear  to be consistent with  an 
hypothesis that  the persistence of the originally injected antigen  in  critical 
tissues is directly or  indirectly  responsible  for  inhibition  of  the  immune 
response to this antigen at subsequent challenge.  In support of this, the dura- 
tion  of the unresponsive state is directly related  to the  amount of antigen 
given at birth. Regardless of the amount of BSA given at birth,  calculations 
based upon the assumption that the measured antigen disappearance rates in 
the serum can be extrapolated beyond measurable levels, yield the same value 
of from 10  '2 to 10  ~s molecules of BSA, as the total number remaining at a time 
estimated to mark the end of the unresponsive state (i.,., midway between the 
latest age at which unresponsiveness was demonstrated,  and the earliest age 
at which an immune response was observed). Although these figures are subject 
to revision with the availability of more refined data, the order of magnitude 
suggested is a sufficiently  large number of molecules to conceivably play a role 
in suppression of the immune response.  The site at which the hypothetically 
persisting  antigen  localizes  would then be of considerable interest.  The data 
presented would suggest that the critical antigen may be located intracellularly, 
unavailable to passively administered antibody (13), or to antibody produced 
by transferred cells, since such antibody has no effect upon the unresponsive 
state. Only the liver is a known site of prolonged persistence of protein antigen 
in rabbits, although in the reported studies this localization  occurs in associa- 
tion  with  antibody formation  (43)  rather  than  with  an unresponsive  state. 
Studies in progress on  the relative  antigen  concentration  in various  organs 
and cells of the young and unresponsive rabbit, compared with that of adult 
animals,  and its association with various nucleoprotein fractions, may provide 
more precise information on the localization  and significance of antigen in the 
unresponsive animal. 
A review of the various experimental models of immunological  tolerance re- 
veals considerable data  bearing  upon  the finding  that  a  continuous  supply 
of  antigen  is  necessary  to  maintain  a  prolonged  state  of unresponsiveness. 
Germane  to  the present  studies are recent investigations of Wolf and  asso- 
ciates  (44)  demonstrating  specific  suppression  of  the  precipitin  response  in 
chickens by intraperitoneal administration of BSA within 50 hours of hatching. 
Little or no precipitin formation occurred in these animals upon challenge  at 6 
weeks of age, but by 12 weeks, only a slight statistical difference from controls 246  1M'MU'NOLOGICAL  D-NR~$PONSIVEN'JESS  IN  RABBITS 
in mean precipitins titers was found. In mice (45)~ a single neonatal injection 
of 18 to 3fi rag.  BSA induces a state of tolerance to anaphylatic sensitization 
present at 7 weeks,  but not at I0 weeks of age.  Similar  results in mice have 
been obtained independently by Tortes and Hughes (46). 
Less clearly related to the present studies are those in which adult rabbits 
were injected  with  massive  amounts  of heterologous  proteins  (13)  or BSA 
(28),  resulting in prolonged antigen  clearance and failure to form the corre- 
sponding precipitating  antibody. Most of the animals in these studies could 
produce precipitating  antibody to BSA after final  clearance  of the  antigen, 
however. Sufficient  data are not available to determine with finality whether 
the amount of antigen required at birth to induce unresponsiveness might be 
quantitatively similar,  when related to body mass, to that required to suppress 
the immune response in adult animals.  Such calculations as may be made from 
existing data suggest that a much larger amount per unit of weight, is required 
for suppressing the adult immune response to BSA, adding to other evidence 
that the production of unresponsiveness requires the special conditions present 
in the newborn period or perhaps in the x-irradiated rabbit (13), but not in the 
adult animal. 
Simonsen (39) was able to suppress agglutinin  formation to turkey and goose 
erythrocytes in chickens  at 6 weeks of age by injection of the  corresponding 
erythrocytes before hatching;  later challenge,  however, demonstrated no sup- 
pression of immunity. Hasek (38) partially suppressed both precipitin  forma- 
tion  after  goose  serum protein  injection  and  agglutinin  formation  to  goose 
erythrocytes in 8 week old ducks by a  single injection of goose erythrocytes 
after  15 days' incubation.  By repeated injections starting  at hatching,  how- 
ever, nearly complete suppression of agglutinin formation lasted at least until 
25 weeks of age.  By analogy,  the  foreign cell precursors  persisting  in  both 
naturally occurring  (47), and artificially induced (38) blood cell chimera,  might 
provide a continuous source of antigen. 
With respect to pneumococcal polysaccharide, clear-cut evidence is available 
that persistent antigen is associated with suppression  of the specific precipitin 
response  to this antigen  (48). Like unresponsiveness  to defined protein,  "im- 
munological  paralysis" is highly specific, (49, 50) dose-dependent, and lasts at 
least  as  long  as  antigen  persists  (51,  52).  However,  apparently  unlike  the 
present or other similar  models,  it may be induced in adults with appropriate 
amounts of antigen, and passively administered antibody is bound by the per- 
sisting  antigen.  The  relation  of this  phenomenon  to  the  other  examples  of 
tolerance therefore remains moot until more data are available. 
The data on tolerance of homografted tissue or tumors induced by neonatal 
or prenatal  injection of viable cells also do not relate clearly to the present 
studies. It seems reasonable, however, to interpret  the function of the viable 
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source of antigens which suppress transplantation immunity, analogous to the 
requirement of a continuous supply of antigen for prolonged unresponsiveness 
to  defined proteins.  The  observation  (11)  that  acquired  tolerance to homo- 
grafts is reversed by giving  tolerant mice normal adult isologous cells, might 
then be interpreted as a means of bringing about rejection of the original  cells 
at the same time as the homograft, thus destroying the source of transplanta- 
tion antigens. Until more is known of the nature and number of tissue antigens 
involved  in  transplantation  immunity,  these  suggestions  remain  highly 
speculative. 
In conclusion,  the present study and the available data from similar experi- 
mental models,  indicate tentatively that  the requirements for prolonged im- 
munological tolerance include:  (a)  initial  exposure to a  threshold amount of 
the antigen around the time of birth, and (b) a continuous source of the anti- 
gen. The critical question of how this antigen inhibits rather than initiates a 
specific immune response remains unanswered.  The answer to this question, 
however, appears fundamental  to  an understanding  of immunological  toler- 
ance as well as of acquired immuuity~ and does not appear to be satisfactorily 
accounted for in any of the current theories of acquired immunity (54-56). 
SlJ~r~l~y 
The  phenomenon  of immunological  unresponsiveness induced  in  the  neo- 
natal rabbit by a single injection of a defined protein antigen, has been char- 
acterized semiquantitatively, and studies bearing upon the mechanism of such 
unresponsiveness have been presented. 
A  single  intraperitoneal  injection  at  birth  of  10 to  100 rag.  BSA, HGG, 
ovalbumin, or a  human macroglobulin,  or an oral feeding of  100 mg.  BSA, 
induced a  state of unresponsiveness lasting at least 90 to  120 days.  100 rag. 
BSA given from birth to 17 days of age, but not later, produced unresponsive- 
ness of 90 to 120 days' duration. 
Data  are presented  which show that  the duration  of unresponsiveness is 
finite and related to the amount of antigen given at birth, and that it may be 
indefinitely prolonged by repeated injections of antigen. 
Disappearance of injected antigen in the unresponsive animal was exponen- 
tial with time,  with no accelerated or immune phase. Administration  of the 
antigen in adjuvants resulted in significant  shortening of the duration of un- 
responsiveness.  The transfer of immune cells to the unresponsive host while 
resulting  in vicarious antibody formation,  did not affect the underlying un- 
responsive state. 
Negative results of attempts  to produce unresponsiveness to a  variety of 
bacterial antigens  are presented. The implications of the data are discussed, 
particularly in reference to the other experimental models of immunological 
tolerance,  and to the various theories of acquired immunity.  It is clear that 248  IMMUNOLOGICAL  UNRESPONSIVENESS IN RABBITS 
any satisfactory theoretical explanation of acquired  immunity will have  to 
account simultaneously for the phenomena of immune tolerance. 
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